Skip to main content

ScienceDex / Researcher record

Araldi, Gian Luca

From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.

FY2019 NIH rank #3,650
  • Rising Star
  • Diverse Portfolio

NIH Funding · FY2019

$1.8M
Full award amounts, FY2019
5
Records listing this PI
#3,650
By linked amount among FY2019 PIs
2015
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2015$55,5001#37,960
2016$109,5002#36,147
2017$621,3012#13,235
2018$316,9992#28,093
2019$1,815,0565#3,650
2020$375,8621#14,844
2021$40,0001#45,871
2022$982,9992#10,063
2023$1,588,5602#5,325

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20151 record
  2. FY20162 records
  3. FY20172 records
  4. FY20182 records
  5. FY2019 · selected5 records
  6. FY20201 record
  7. FY20211 record
  8. FY20222 records
  9. FY20232 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Araldi, Gian Luca. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2019 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2019 award records by amount

NIH award records listing Araldi, Gian Luca as a PI. Multi-PI records show the full award amount for context.

  • 4R44AG056181-02R44Contact PI
    Development of DYRK1A allosteric modulator for the treatment of Alzheimer’s Disease
    $971.3K
    award amount
  • 1R43AG063560-01R43Contact PI
    DYRK1A inhibitors as therapeutic approach to Tau hyper-phosphorylation for treatment of Alzheimer disease and other CNS disorders
    $449.4K
    award amount
  • 3R44AG056181-02S1R44Contact PI
    Development of DYRK1A allosteric modulator for the treatment of Alzheimer’s Disease
    $350K
    award amount
  • 271201400011I-P00001-27100005-1N02Contact PI
    ARALDI, GIAN LUCA:1238759 [18-006556]
    $24.3K
    award amount
  • 75N95019P00595-0-0-1N02Contact PI
    TO PROVIDE THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) BLUEPRINT NEUROTHERAPEUTICS NETWORK (BPN) WITH PROCESS CHEMISTRY CONSULTANT SUPPORT SERVICES IN ACCORDANCE WITH THE GOVE
    $20K
    award amount

Award organizations

Organizations that administered FY2019 awards listing Araldi, Gian Luca as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2015
    First NIH Award
    Avanti Biosciences, Inc.
  2. 2016
    Multi-Institutional Research
    Awards at 2 institutions
  3. 2017
    $500K Cumulative Funding
  4. 2018
    $1M Cumulative Funding
  5. 2019
    $2M Cumulative Funding
  6. 2019
    Entered Top 50% Nationally
    Ranked #3650
  7. 2019
    Entered Top 25% Nationally
    Ranked #3650
  8. 2023
    $5M Cumulative Funding